<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The cardiorenal syndrome in patients with <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> represents a systemic condition that affects both the cardiovascular and renal systems </plain></SENT>
<SENT sid="1" pm="."><plain><z:mp ids='MP_0002055'>Diabetes</z:mp> is a well established risk factor for <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e>), and a significant proportion of diabetic patients go on to develop clinically significant <z:hpo ids='HP_0000112'>nephropathy</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>In the diabetic state the kidney is involved by progressive <z:mp ids='MP_0000612'>sclerosis</z:mp>/<z:mp ids='MP_0003045'>fibrosis</z:mp> and <z:hpo ids='HP_0000093'>proteinuria</z:hpo>, due most likely to overactivity of the transforming growth factor-beta system and, to some extent, the vascular endothelial growth factor system, respectively </plain></SENT>
<SENT sid="3" pm="."><plain>The pathogenesis of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> in <z:mp ids='MP_0002055'>diabetes</z:mp> is multifactorial, involving hemodynamic forces, humoral/metabolic factors, and <z:mp ids='MP_0003674'>oxidative stress</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain>Additionally, it has been suggested that <z:e sem="disease" ids="C0856169" disease_type="Disease or Syndrome" abbrv="">endothelial dysfunction</z:e> may lead to simultaneous development and progression of renal and cardiac pathology in <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="5" pm="."><plain>The risk of microvascular complications can be reduced by intensive glycemic control in patients with type 1 and type 2 <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> whereas benefit to the cardiovascular system is less clear </plain></SENT>
<SENT sid="6" pm="."><plain>However, intensified intervention involving other <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> risk factors like <z:hpo ids='HP_0000822'>hypertension</z:hpo> and dyslepidemia and interception of the rennin-angiotensin-<z:chebi fb="0" ids="27584,30834">aldosterone</z:chebi> system in patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> have been shown to be associated with significant reduction in the risk for <z:e sem="disease" ids="C0022658" disease_type="Disease or Syndrome" abbrv="">renal disease</z:e> progression that was paralleled by a significant reduction in <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e> burden </plain></SENT>
</text></document>